ACCESS Newswire
03 Aug 2022, 22:07 GMT+10
NEW YORK, NY / ACCESSWIRE / August 3, 2022 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers Phathom Pharmaceuticals, Inc. ('Phathom' or 'the Company') (NASDAQ:PHAT). Investors who purchased Phathom shares are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/phat.
The investigation concerns whether Phathomviolated federal securities laws.
On August 2, 2022, Phathom issued a press release titled: 'Phathom Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Updates,' which announced that 'we detected trace levels of a nitrosamine in vonoprazan drug product in our post-approval testing as we prepared for commercial launch.' The release continues that based on this detection, 'the Company is working with the FDA and plans to obtain approval of and implement an additional test method, specification, including a proposed acceptable intake limit, and additional controls to address this impurity prior to releasing our first vonoprazan-based products to the market.' Phathom said that 'these additional activities will result in a delay of the planned VOQUEZNA DUAL PAK and VOQUEZNA TRIPLE PAK product launches.' Following this news, Phathom stock dropped almost 29% on that same day.
If you are aware of any facts relating to this investigation or purchased Phathom shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/phat. You can also contact Peretz Bronstein or law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | [email protected]
SOURCE: Bronstein, Gewirtz & Grossman, LLC
Get a daily dose of Miami Mirror news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Miami Mirror.
More InformationCALGARY, Canada: Canada's carbon pricing policy, long a central pillar of its climate strategy, is facing mounting pressure as political...
NEW BRUNSWICK, New Jersey: Johnson & Johnson is ramping up its U.S. investments even as global trade tensions resurface with plans...
WASHINGTON, D.C./DUBAI: The United Arab Emirates is significantly expanding its financial footprint in the U.S. with a new investment...
NEW YORK, New York - Investors bought up stocks on U.S. markets Monday after President Donald Trump indicated he may pull back on some...
BOSTON, Massachusetts: Private equity investor William Chisholm has agreed to buy the Boston Celtics in a record-breaking deal worth...
WASHINGTON, D.C.: The cost of borrowing for a home in the U.S. ticked up again this week, marking the second straight increase as homebuyers...
WASHINGTON, D.C.: Ten Democratic lawmakers in the U.S. House of Representatives have asked the Pentagon to reduce military training...
TORONTO, Canada: An initial investigation into last month's dramatic Delta Air Lines crash-landing in Toronto has revealed that the...
NEW YORK CITY, New York: New York State's highest court has struck down a law this week that would have allowed over 800,000 legal...
The death toll in Gaza on the weekend has passed 50,000, local health authorities have reported. What started the carnage was the Hamas-led...
WASHINGTON, D.C.: The U.S. Department of Agriculture (USDA) has announced plans to invest up to US$100 million in research to develop...
WASHINGTON, D.C.: The U.S. Department of Health and Human Services (HHS) has removed a 2024 advisory from its website that called gun...